{
    "SPADE_UN_26590": {
        "Sequence Information": {
            "Peptide Name": "LL-37 RIK-10 [I2W,D4R,L9W], RIK-10+",
            "Sequence": "RWKRFLRNWV",
            "Sequence Length": 10,
            "Biological Activity": [
                "Anti-Gram+",
                "Anti-Gram-",
                "Anticancer",
                "Anti-Mammalian Cell",
                "Antibiofilm"
            ],
            "Binding Target": "1. Lipid Bilayer",
            "Source": "",
            "Gene": "",
            "PDB ID": "",
            "UniProt Entry": [
                {
                    "uniprotId": "P49913",
                    "uniprotUrl": "http://www.uniprot.org/uniprot/P49913",
                    "description": "The amino acid sequence of the current peptide coincides with the part of the UniProt entry that represents a peptide precursor."
                }
            ],
            "Literature": [
                {
                    "Title": "Segment-Based Peptide Design Reveals the Importance of N-Terminal High Cationicity for Antimicrobial Activity Against Gram-Negative Pathogens",
                    "Pubmed ID": "39377976",
                    "Reference": "Probiotics Antimicrob Proteins. 2024;doi: 10.1007/s12602-024-10376-3:",
                    "Author": "Mechesso AF, Zhang W, Su Y, Xie J, Wang G",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/39377976"
                }
            ],
            "Mass": 1460.73,
            "PI": 12.0,
            "Net Charge": 4,
            "Hydrophobicity": -1.19,
            "Frequent Amino Acids": "RWF",
            "Absent Amino Acids": "ACDEGHIMOPQSTUY",
            "Basic Residues": 4,
            "Acidic Residues": 0,
            "Hydrophobic Residues": 3,
            "Polar Residues": 7,
            "Positive Residues": 4,
            "Negative Residues": 0,
            "SPADE ID": "SPADE_UN_26590",
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_N_11398",
                    "Similarity": 1.0,
                    "Sequence": "WRWKWRWK"
                },
                {
                    "SPADE_ID": "SPADE_N_11969",
                    "Similarity": 1.0,
                    "Sequence": "KWWCFRVCYRGICYRRCRWK"
                },
                {
                    "SPADE_ID": "SPADE_N_11970",
                    "Similarity": 1.0,
                    "Sequence": "KWWVFRVVYRGIVYRRVRWK"
                }
            ],
            "Hemolytic Activity": "Human erythrocytes:<5% Hemolysis=100 µM,Human erythrocytes:18% Hemolysis=400 µM,Human keratinocytes HaCat:50% Cell death=100 µM",
            "Target Organism": "Staphylococcus aureus USA 300 LAC(MIC=16µM),Staphylococcus aureus USA 300 LAC(MIC=>32µM),Staphylococcus aureus USA 300 LAC(MIC=8µM),Staphylococcus aureus USA 300 LAC(MIC=>32µM),Staphylococcus epidermidis 1457(MIC=>32µM),Pseudomonas aeruginosa E411-17(MIC=4µM),Pseudomonas aeruginosa E411-17(MIC=8µM),Pseudomonas aeruginosa E411-17(MIC=>32µM),Escherichia coli E423-17(MIC=4µM),Acinetobacter baumannii B28-16(MIC=8µM),Human hepatocellular carcinoma HepG2(50-60% Cytotoxicity=100µM),Human lung carcinoma A549(30-40% Cytotoxicity=100µM)"
        }
    }
}